Sterling Capital Management LLC Trims Position in Roche Holding AG (OTCMKTS:RHHBY)

Sterling Capital Management LLC trimmed its position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,064 shares of the company's stock after selling 7,512 shares during the quarter. Sterling Capital Management LLC's holdings in Roche were worth $3,174,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of RHHBY. Brooklyn Investment Group grew its position in Roche by 36.6% during the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company's stock worth $48,000 after buying an additional 363 shares in the last quarter. Verity Asset Management Inc. grew its holdings in shares of Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after purchasing an additional 1,697 shares in the last quarter. HighPoint Advisor Group LLC increased its position in shares of Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after purchasing an additional 304 shares during the last quarter. Confluence Investment Management LLC raised its stake in Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company's stock valued at $488,000 after purchasing an additional 2,910 shares in the last quarter. Finally, SVB Wealth LLC bought a new stake in Roche during the fourth quarter valued at approximately $555,000.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on RHHBY. UBS Group upgraded Roche from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 13th. Morgan Stanley assumed coverage on Roche in a report on Wednesday, February 12th. They set an "equal weight" rating on the stock. Finally, Sanford C. Bernstein upgraded Roche to a "strong-buy" rating in a research report on Thursday, January 30th. Two analysts have rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Roche currently has an average rating of "Moderate Buy".

Remove Ads

Roche Price Performance

OTCMKTS RHHBY opened at $38.10 on Friday. The company has a 50-day simple moving average of $41.04 and a two-hundred day simple moving average of $38.58. Roche Holding AG has a 12-month low of $29.20 and a 12-month high of $44.31. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.